ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

HHS Reports Some Gains In Reducing Health Disparities

February 8, 2002

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005

Sen. Dole Raps HEW Over Delays On Patent Requests

August 11, 1978

European Commission Approves Subcutaneous Rituximab

March 28, 2014

Consensus Conference Recommends Adjuvant Chemotherapy In Breast Cancer Only For Premenopausal Women

July 25, 1980

Senate Resolution Urges CMS To Reopen Coverage Policy on ESAs In Oncology.

September 7, 2007